Chemically induced Pluripotent Stem Cells (CiPSCTM) for Practical, Safe, Clinical Translation of Human iPS TechnologyTuesday, 25 January 2011 at 16:00 Add to Calendar ▼2011-01-25 16:00:002011-01-25 17:00:00Europe/LondonChemically induced Pluripotent Stem Cells (CiPSCTM) for Practical, Safe, Clinical Translation of Human iPS TechnologyStem Cells World Congress in San DiegoSan DiegoSELECTBIOenquiries@selectbiosciences.com DNAmicroarray, Inc. has developed a robust iPS methodology termed “Chemically induced Pluripotent Stem Cells” (CiPSCTM, patent pending) that uses a cocktail of small molecule inducers. CiPSC eliminates the need for any exogenous gene transduction and generates fully reprogrammed cells with high levels of efficiency. In addition, CiPSC uses non-invasive samples (e.g. skin biopsies) to derive personalized pluripotent stem cells without abnormal or permanent modifications to the cellular and molecular machinery. |